Daehwa Pharmaceutical Co., Ltd.

Quick facts

Phase 2 pipeline

• DHP107 · Diabetes
  DHP107 is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2).
• DHP1401

Phase 1 pipeline

• DHP2302R1
• DHP2302R2
• DHP2306R1
• DHP2306R2

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Daehwa Pharmaceutical Co., Ltd. portfolio CI brief
• Daehwa Pharmaceutical Co., Ltd. pipeline updates RSS